NEW YORK, NY — On October 13, as the sun sets, a vast, synchronized display of light will ripple across the globe. From the iconic silhouette of New York’s One World Trade Center to the majestic cascades of Niagara Falls and the historic streets of Inverness, Scotland, more than 325 landmarks will be bathed in the colors of teal, green, and pink. This is not merely a visual spectacle; it is a desperate, hopeful, and urgent cry for attention.
The campaign, known as #LightUpMBC, marks National Metastatic Breast Cancer (MBC) Awareness Day. While October is widely recognized as Breast Cancer Awareness Month, METAvivor Research and Support, the organization behind the campaign, emphasizes that the realities of Stage 4 metastatic breast cancer are frequently obscured by the mainstream focus on early detection and prevention. By turning the world’s most recognizable structures into beacons of awareness, organizers aim to bridge the gap between public perception and the stark, terminal reality faced by thousands of patients.
The Reality of Stage 4: Why This Day Matters
To understand the urgency of #LightUpMBC, one must first confront the gravity of the diagnosis. Metastatic breast cancer occurs when cancer cells spread from the primary site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. While it is still classified as breast cancer, the diagnosis represents a profound shift in the patient’s journey.
For the thousands of Americans living with MBC, there is no "end" to treatment. Even when clinical scans show "no evidence of disease"—a status that often misleads the public into thinking a patient is "cured"—the cancer remains. It is a chronic, life-limiting condition that requires constant medical vigilance. Because cancer cells frequently become resistant to existing therapies, patients are often forced to cycle through a series of treatments, each carrying its own heavy toll on the body and spirit.
The statistics provided by health authorities are sobering: an estimated 42,670 people in the United States are projected to die from breast cancer in 2026. This equates to approximately 117 lives lost every single day. For these patients, research is not an abstract scientific endeavor; it is the literal difference between life and death.
Chronology of a Movement: From a Local Wish to a Global Beacon
The origins of #LightUpMBC are rooted in the deeply personal story of Jessica Moore, who passed away from metastatic breast cancer at the age of 36. Her friend, Laura Inahara, founded the campaign to honor Jessica’s wish: to see one local landmark illuminated to raise awareness for a disease that felt invisible to the outside world.
- 2017: The movement began humbly when Portsmouth’s Memorial Bridge in New Hampshire became the first landmark to light up in the official MBC awareness colors: teal, green, and pink.
- 2018–2025: What started as a small, local initiative grew exponentially through social media advocacy and the tireless work of the MBC community. The campaign expanded from a few regional bridges to national icons, crossing borders into Canada, the Philippines, and across Europe.
- 2026: Today, the campaign encompasses 325 landmarks spanning 50 U.S. states, 20 countries, and 195 cities. It has evolved from a simple lighting event into a sophisticated, global advocacy engine that has raised over $2.7 million for research.
Supporting Data: The Case for Targeted Research
METAvivor remains unique in the landscape of cancer non-profits: it is the only organization that exclusively funds Stage 4 metastatic breast cancer research. The organization’s philosophy is rooted in the recognition that while early detection saves lives, the current funding landscape is heavily skewed toward early-stage research.
The funding process employed by METAvivor is rigorous. Grants are awarded only after a dual-track review process involving both professional scientists and patient advocates. This ensures that the research funded is not only scientifically sound but also directly relevant to the quality of life and survival outcomes for those actually living with the disease.
The financial data underscores the mission: 100% of net proceeds from the #LightUpMBC campaign and the accompanying livestream go directly toward these research grants. As medical science pushes the boundaries of immunotherapy and precision medicine, the capital raised by this campaign provides the seed money necessary for researchers to test high-risk, high-reward theories that traditional, more conservative funding bodies might overlook.
Official Responses: Voices from the Front Lines
The leadership of the MBC community emphasizes that awareness is only the first step; action is the ultimate goal.
Dr. Kelly Shanahan, the Board President of METAvivor, offers a perspective that is both clinical and profoundly personal. Diagnosed with MBC in 2013, she admits she never expected to see the 13-year milestone. "My hope and the hope of so many others lies in research," Dr. Shanahan stated. "METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
The campaign’s founder, Laura Inahara, reflects on the legacy of her late friend, Jessica Moore. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has raised millions for critical research."
LightUpMBC Live: A Global Digital Gathering
The centerpiece of the awareness campaign is the #LightUpMBC Live event, which will be broadcast on October 13 at 8 p.m. ET (5 p.m. PT). Hosted by Tami Eagle Bowling—who has been living with metastatic breast cancer for 11 years—and Broadway performer Kara Lindsay, the event is designed to humanize the statistics.
The program promises to be an emotional and educational journey, featuring:
- Patient Stories: Real-time testimonials from individuals living with Stage 4 disease, broadcasting from the bases of illuminated landmarks.
- Scientific Insights: Expert perspectives on the latest breakthroughs in MBC treatment and the future of oncology.
- Artistic Performances: A series of musical segments featuring luminaries such as two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, and others who have donated their time to support the cause.
The event will be available for free on the METAvivor YouTube channel, Facebook Live, and via the streaming platform LiveOne.
Implications for the Future: Transforming the Diagnosis
The ultimate objective of METAvivor and the #LightUpMBC campaign is to fundamentally change the nature of an MBC diagnosis. Currently, the medical community and the public largely treat Stage 4 breast cancer as an inevitably terminal sentence. The goal is to transform this into a manageable, chronic condition where patients can live for years, or even decades, with a high quality of life.
The implications of this shift are immense. It would mean that a diagnosis of metastatic disease would no longer carry the immediate weight of "end-of-life" planning, but rather transition into a model of long-term care similar to managing diabetes or heart disease.
To achieve this, the public is being called upon to do more than just watch the lights. Supporters are encouraged to photograph their local illuminated landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor. By flooding digital spaces with these images, the movement seeks to force the conversation into the public sphere, ensuring that the needs of Stage 4 patients are no longer sidelined during Breast Cancer Awareness Month.
For those wishing to contribute directly, the campaign website, www.lightupmbc.org, serves as a central hub for donations, viewing links for the livestream, and a map of the participating landmarks.
As the lights flicker on across the world on October 13, they will serve as a reminder that behind every statistic is a human being, and behind every diagnosis is a desperate, burning need for science to catch up to the resilience of those who refuse to give up.
About the Author
